These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5616881)

  • 1. [Pathogenic and immunogenic properties of a streptomycin dependent mutant of Salmonella gaertneri].
    Sergeev VV; Taratorina OM; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):56-60. PubMed ID: 5616881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study of the stability of avirulent properties and the immunogenicity of suppressor revertants of streptomycin-dependent salmonella mutants].
    Shuster BIu; Likhoded VG
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):40-4. PubMed ID: 797191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of Salmonellas as a vector in the designing of recombinant vaccines].
    Boĭchenko MN; Vorobév AA
    Vestn Ross Akad Med Nauk; 1997; (3):43-6. PubMed ID: 9181857
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccinal properties of Salmonella abortus ovis mutants for streptomycin: screening with a murine model.
    Lantier F; Pardon P; Marly J
    Infect Immun; 1981 Nov; 34(2):492-7. PubMed ID: 7309235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant Salmonella.
    Ornellas EP; Roantree RJ; Steward JP
    J Infect Dis; 1970 Feb; 121(2):113-23. PubMed ID: 4905646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of immunogenesis in vaccination with streptomycin-dependent mutants of Salmonella and Shigella. I. Dynamics of seeding of the organism and reaction of the macrophages].
    Frolova MA; Sergeev VV; Golubeva OS; Protasova OV; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):96-100. PubMed ID: 5477614
    [No Abstract]   [Full Text] [Related]  

  • 7. [Virulent and immunogenic properties of streptomycin- and guanine-dependent mutant of S. typhimurium].
    Elkina SI; Sergeev VV; Shuster BIu; Limarev VA; Likhoded VS
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Jan; 48(1):10-3. PubMed ID: 4928696
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccinal properties of Salmonella abortusovis mutants for streptomycin: screening with an ovine model.
    Pardon P; Marly J; Lantier F; Sanchis R
    Ann Rech Vet; 1990; 21(1):57-67. PubMed ID: 2344139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant-attenuated Salmonella vaccines modified to reduce virulence.
    Constable L
    Expert Rev Vaccines; 2011 Aug; 10(8):1117. PubMed ID: 21961199
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccines against diarrheal diseases of bacterial origin].
    Le Minor L
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):331-9. PubMed ID: 3914235
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease.
    Rüssmann H
    Int J Med Microbiol; 2004 Apr; 293(7-8):565-9. PubMed ID: 15149032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The isolation and characteristics of the biological and genetic properties of neamin-resistant mutants of Salmonella abortus-ovis that are promising for vaccine creation].
    Marakusha BI; Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):11-7. PubMed ID: 2385985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella vaccines with mutations in the phoP virulence regulon.
    Miller SI; Mekalanos JJ; Pulkkinen WS
    Res Microbiol; 1990; 141(7-8):817-21. PubMed ID: 2101471
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic manipulation of Salmonella serotype Bovismorbificans to aromatic-dependence and evaluation of its vaccine potential in mice.
    Mukkur TK; Stocker BA; Walker KH
    J Med Microbiol; 1991 Jan; 34(1):57-62. PubMed ID: 1990138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution to the study of live streptomycin-dependent Salmonella vaccines: the problem of reversion to a virulent form.
    Vladoianu IR; Dubini F; Bolloli A
    J Hyg (Lond); 1975 Oct; 75(2):203-14. PubMed ID: 1100711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of Salmonella cultures. IV. Immunogenicity of Salmonella resistant to antibiotics].
    Minev M
    Vet Med Nauki; 1975; 12(9):66-73. PubMed ID: 1108410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical and immunological studies on lipopolysaccharides of streptomycin-dependent mutants of Salmonella enteritidis.
    Stanislavski ES; Edvabnaja LS; Sergejev VV; Zhvaneckaja MI; Rostovceva NA
    Immunochemistry; 1971 Jan; 8(1):49-62. PubMed ID: 4100765
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of eight rough mutants of Salmonella gallinarum.
    Cameron CM; Fuls WJ; van Reenen L
    Onderstepoort J Vet Res; 1972 Sep; 39(3):139-46. PubMed ID: 4664248
    [No Abstract]   [Full Text] [Related]  

  • 20. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.
    Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R
    Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.